EKSO
Ekso Bionics Holdings, Inc. NASDAQ$11.80
Mkt Cap $28.6M
52w Low $2.73
84.2% of range
52w High $13.50
50d MA $10.64
200d MA $6.79
P/E (TTM)
-2.4x
EV/EBITDA
-2.3x
P/B
3.2x
Debt/Equity
0.3x
ROE
-750.7%
P/FCF
-1.7x
RSI (14)
—
ATR (14)
—
Beta
0.78
50d MA
$10.64
200d MA
$6.79
Avg Volume
97.9K
About
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineer…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | AMC | -0.03 | -2.04 | -6700.0% | 11.21 | -0.1% | +2.1% | +7.1% | +5.2% | +5.3% | — | — |
| Feb 23, 2026 | AMC | -0.08 | -1.56 | -1850.0% | 10.64 | +0.0% | -4.4% | -9.4% | -5.8% | -4.7% | -3.9% | — |
| Oct 28, 2025 | AMC | -0.99 | -0.54 | +45.5% | 4.81 | -0.2% | +9.1% | +6.0% | +12.1% | +7.3% | +6.7% | — |
| Jul 28, 2025 | AMC | -1.20 | -1.24 | -3.3% | 4.53 | -19.2% | -27.4% | -19.9% | -23.2% | -23.0% | -27.4% | — |
| May 5, 2025 | AMC | -1.65 | -1.80 | -9.1% | 7.15 | -14.8% | -9.1% | -8.0% | -13.3% | -10.5% | -9.8% | — |
| Mar 3, 2025 | AMC | -0.07 | -0.14 | -100.0% | 7.23 | -2.5% | -1.2% | -9.1% | -16.5% | -19.9% | -27.4% | — |
| Oct 28, 2024 | AMC | -0.08 | -0.10 | -25.0% | 16.95 | -20.1% | -15.0% | -17.5% | -24.2% | -21.5% | -22.9% | — |
| Jul 29, 2024 | AMC | -0.11 | -0.13 | -18.2% | 22.35 | -16.8% | -28.9% | -29.5% | -29.5% | -32.9% | -34.2% | — |
| Apr 29, 2024 | AMC | -0.16 | -0.20 | -25.0% | 19.35 | +0.8% | -3.9% | -1.6% | +0.0% | +1.6% | +4.7% | — |
| Mar 4, 2024 | AMC | -0.11 | -0.22 | -100.0% | 31.50 | -16.2% | -24.8% | -28.6% | -24.8% | -26.7% | -33.3% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $10.58 | $9.56 | -9.6% | -18.3% | -25.9% | -19.2% | -9.9% | -16.6% |
| Nov 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.16 | $4.16 | +0.0% | +0.5% | -3.1% | -7.0% | -1.9% | +1.4% |
| Jul 29 | Lake Street | Maintains | Buy → Buy | — | $4.53 | $3.66 | -19.2% | -27.4% | -19.9% | -23.2% | -23.0% | -27.4% |
| May 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.15 | $6.09 | -14.8% | -9.1% | -8.0% | -13.3% | -10.5% | -9.8% |
| Mar 4 | Lake Street | Maintains | Buy → Buy | — | $7.23 | $7.05 | -2.5% | -1.2% | -9.1% | -16.5% | -19.9% | -27.4% |
| Mar 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.23 | $7.05 | -2.5% | -1.2% | -9.1% | -16.5% | -19.9% | -27.4% |
| Jan 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.68 | $11.04 | +3.4% | -2.5% | -8.7% | -3.0% | -8.5% | -11.0% |
| Oct 29 | Lake Street | Maintains | Buy → Buy | — | $16.95 | $13.55 | -20.1% | -15.0% | -17.5% | -24.2% | -21.5% | -22.9% |
| Oct 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.95 | $13.55 | -20.1% | -15.0% | -17.5% | -24.2% | -21.5% | -22.9% |
| Jul 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $22.35 | $18.60 | -16.8% | -28.9% | -29.5% | -29.5% | -32.9% | -34.2% |
Recent Filings
8-K · 1.01
! Medium
Ekso Bionics Holdings, Inc. -- 8-K 1.01: Equity Issuance
Ekso Bionics raised $15.75 million through an equity issuance to APLD Intermediate HoldCo LLC, diluting existing shareholders but providing capital for operations and growth.
May 4
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
EKSO's equity incentive plan diluting existing shareholders by ~5.25% signals management confidence in growth, but investors should monitor whether operational performance justifies this significant ownership stake reduction.
Apr 16
8-K · 1.01
! Medium
Ekso Bionics Holdings, Inc. -- 8-K 1.01: Equity Issuance
Ekso Bionics completed an equity exchange with APLD Intermediate HoldCo LLC, potentially diluting existing shareholders while bringing in new capital or strategic backing.
Feb 17
Data updated apr 25, 2026 6:47am
· Source: massive.com